Inari Medical Inc. [NASDAQ: NARI] closed the trading session at $65.79 on 11/18/20. The day’s price range saw the stock hit a low of $64.61, while the highest price level was $67.8299. The company report on November 13, 2020 that Inari Medical Announces Presentation of Positive 30-Day Follow-Up Results from First Patients in Real World FLASH Registry.
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced follow-up results of the first 230 patients enrolled in its FLASH study. FLASH is a real world registry to study the FlowTriever system in intermediate- and high-risk pulmonary embolism (“PE”) patients. The results were strongly positive. Just one death (0.4%) was reported at 30 days. By contrast, the national PERT Consortium® Quality Database recently showed 30-day mortality rates of 25.9% and 6.1% for high- and intermediate-risk PE patients. In addition, the FLASH Registry showed a readmission rate of 6.7%, compared to the nearly 25% readmission rate shown in the PERT Database. Efficacy data were equally compelling, showing normalization or near normalization in a battery of hemodynamic variables like pulmonary artery pressure, RV/LV ratio, and heart rate, as well as dyspnea (shortness of breath) metrics.
FLASH is a 500-patient prospective, multicenter, single-arm registry evaluating real world patient outcomes after treatment of PE with FlowTriever. Interim data were obtained across 19 US sites, and results were presented virtually by National Principal Investigator, Catalin Toma, MD, Director of Interventional Cardiology at UPMC Heart & Vascular Institute in Pittsburgh, PA at the American Heart Association (“AHA”) Scientific Sessions 2020.
The stocks have a year to date performance of 54.76 percent and weekly performance of -14.77 percent. The stock has performed -4.07 percent around the most recent 30 days and changed -7.04 percent over the most recent 3-months.
If compared to the average trading volume of 319.06K shares, NARI reached to a volume of 3184976 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Inari Medical Inc. [NARI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NARI shares is $70.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NARI stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Inari Medical Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 18, 2020. While these analysts kept the previous recommendation, Morgan Stanley raised their target price from $66 to $76. The new note on the price target was released on October 29, 2020, representing the official price target for Inari Medical Inc. stock. Previously, the target price had yet another raise to $80, while SVB Leerink analysts kept a Outperform rating on NARI stock.
The Average True Range (ATR) for Inari Medical Inc. is set at 5.53, with the Price to Sales ratio for NARI stock in the period of the last 12 months amounting to 37.56. The Price to Book ratio for the last quarter was 8.69, with the Price to Cash per share for the same quarter was set at 3.94.
NARI stock trade performance evaluation
Inari Medical Inc. [NARI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.77.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NARI stock in for the last two-week period is set at 43.79, with the RSI for the last a single of trading hit 37.20, and the three-weeks RSI is set at 45.46 for Inari Medical Inc. [NARI]. The present Moving Average for the last 50 days of trading for this stock 69.68, while it was recorded at 70.68 for the last single week of trading.
Inari Medical Inc. [NARI]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Inari Medical Inc. [NARI] shares currently have an operating margin of +1.80 and a Gross Margin at +88.59. Inari Medical Inc.’s Net Margin is presently recorded at -2.33.
Return on Total Capital for NARI is now 3.08, given the latest momentum, and Return on Invested Capital for the company is -3.98. Return on Equity for this stock declined to -7.81, with Return on Assets sitting at -3.30. When it comes to the capital structure of this company, Inari Medical Inc. [NARI] has a Total Debt to Total Equity ratio set at 129.64. Additionally, NARI Total Debt to Total Capital is recorded at 56.45, with Total Debt to Total Assets ending up at 43.73.
Reflecting on the efficiency of the workforce at the company, Inari Medical Inc. [NARI] managed to generate an average of -$5,989 per employee. Receivables Turnover for the company is 7.56 with a Total Asset Turnover recorded at a value of 1.42.Inari Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 19.60 and a Current Ratio set at 20.20.
Inari Medical Inc. [NARI]: Insider Ownership positions
There are presently around $569 million, or 54.00% of NARI stock, in the hands of institutional investors. The top three institutional holders of NARI stocks are: ALLIANCEBERNSTEIN L.P. with ownership of 1,338,068, which is approximately 42.74% of the company’s market cap and around 4.60% of the total institutional ownership; PERCEPTIVE ADVISORS LLC, holding 848,500 shares of the stock with an approximate value of $55.82 million in NARI stocks shares; and VANGUARD GROUP INC, currently with $54.34 million in NARI stock with ownership of nearly 62.028% of the company’s market capitalization.
Positions in Inari Medical Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 71 institutional holders increased their position in Inari Medical Inc. [NASDAQ:NARI] by around 3,483,838 shares. Additionally, 46 investors decreased positions by around 2,229,598 shares, while 9 investors held positions by with 2,941,540 shares. The mentioned changes placed institutional holdings at 8,654,976 shares, according to the latest SEC report filing. NARI stock had 46 new institutional investments in for a total of 1,356,179 shares, while 30 institutional investors sold positions of 1,055,699 shares during the same period.